Heyman Richard A.insider trades
In SEC Form 4 filings, Heyman Richard A. is listed as Director of Oric Pharmaceuticals, Inc. (ORIC). In the last 90 days, Heyman Richard A. sold $86.5K of Oric Pharmaceuticals, Inc. (ORIC) on the open market and bought none. All 2 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| ORICOric Pharmaceuticals, Inc. | Director | 4 | Oct 2 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-02
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ORICOric Pharmaceuticals, Inc. | Oct 1 | Oct 2 | M | 3,500 | $1.60 | $5,600 | 41,800 | Yes | Form 4 |
| ORICOric Pharmaceuticals, Inc. | Oct 1 | Oct 2 | S | 3,500 | $12.91 | Sale −$45,199 | 38,300 | Yes | Form 4 |
| ORICOric Pharmaceuticals, Inc. | Oct 1 | Oct 2 | S | 3,200 | $12.91 | Sale −$41,325 | 203,472 | Yes | Form 4 |
| ORICOric Pharmaceuticals, Inc. | Oct 1 | Oct 2 | M · derivative | 3,500 | $1.60 | $5,600 | 26,700 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.